| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2021-06-20 18:01:12 UTC |
|---|
| Updated at | 2021-08-20 00:00:29 UTC |
|---|
| NP-MRD ID | NP0034231 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | lobeline |
|---|
| Provided By | JEOL Database |
|---|
| Description | Lobeline is also known as alpha-lobeline or lobelinum. Lobeline is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. lobeline is found in ampanula medium and Lobelia siphilitica. lobeline was first documented in 2020 (PMID: 33111502). Based on a literature review a small amount of articles have been published on Lobeline (PMID: 33897801) (PMID: 34298167) (PMID: 33762957) (PMID: 32186243). |
|---|
| Structure | [H]O[C@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])[C@@]1([H])N(C([H])([H])[H])[C@@]([H])(C([H])([H])C(=O)C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])C1([H])[H] InChI=1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 2-(6-(2-Hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenylethanone | ChEBI | | 2-(6-(beta-Hydroxyphenethyl)-1-methyl-2-piperidyl)acetophenone | ChEBI | | 8,10-Diphenyllobelionol | ChEBI | | alpha-Lobeline | ChEBI | | Lobelin | ChEBI | | Lobelina | ChEBI | | Lobelinum | ChEBI | | Lobnico | ChEBI | | (-)-Lobeline | Kegg | | 2-(6-(b-Hydroxyphenethyl)-1-methyl-2-piperidyl)acetophenone | Generator | | 2-(6-(Β-hydroxyphenethyl)-1-methyl-2-piperidyl)acetophenone | Generator | | a-Lobeline | Generator | | Α-lobeline | Generator | | Sulfate, lobeline | MeSH | | Lobeline sulfate | MeSH | | Smokeless | MeSH | | Inibsa brand OF lobelin sulfate | MeSH | | Lobeline | ChEBI |
|
|---|
| Chemical Formula | C22H27NO2 |
|---|
| Average Mass | 337.4553 Da |
|---|
| Monoisotopic Mass | 337.20418 Da |
|---|
| IUPAC Name | 2-[(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethan-1-one |
|---|
| Traditional Name | (-)-lobeline |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H]O[C@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])[C@@]1([H])N(C([H])([H])[H])[C@@]([H])(C([H])([H])C(=O)C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])C1([H])[H] |
|---|
| InChI Identifier | InChI=1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1 |
|---|
| InChI Key | MXYUKLILVYORSK-HBMCJLEFSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbonyl compounds |
|---|
| Direct Parent | Alkyl-phenylketones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alkyl-phenylketone
- Benzoyl
- Aryl alkyl ketone
- Aralkylamine
- Monocyclic benzene moiety
- Beta-aminoketone
- Piperidine
- Benzenoid
- 1,3-aminoalcohol
- Tertiary aliphatic amine
- Tertiary amine
- Secondary alcohol
- Organoheterocyclic compound
- Azacycle
- Organopnictogen compound
- Aromatic alcohol
- Amine
- Organonitrogen compound
- Alcohol
- Organic nitrogen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | |
|---|
| Predicted Properties | |
|---|
| General References | - Kulkarni AM, Rampogu S, Lee KW: Computer-Aided Drug Discovery Identifies Alkaloid Inhibitors of Parkinson's Disease Associated Protein, Prolyl Oligopeptidase. Evid Based Complement Alternat Med. 2021 Apr 8;2021:6687572. doi: 10.1155/2021/6687572. eCollection 2021. [PubMed:33897801 ]
- Anand A, Sharma R, Srivastava N, Ramakrishnan S: J receptor activity in idiopathic pulmonary hypertension and its expected change in the presence of pulmonary bed vasodilators. Respir Physiol Neurobiol. 2021 Dec;294:103742. doi: 10.1016/j.resp.2021.103742. Epub 2021 Jul 21. [PubMed:34298167 ]
- Zheng Q, Wang Y, Zhang S: Beyond Alkaloids: Novel Bioactive Natural Products From Lobelia Species. Front Pharmacol. 2021 Mar 8;12:638210. doi: 10.3389/fphar.2021.638210. eCollection 2021. [PubMed:33762957 ]
- Ni C, Li Y, Li Z, Tian L, Fu J, Wu K, Wang Y, Yao M, Ge RS: Cisatracurium stimulates testosterone synthesis in rat and mouse Leydig cells via nicotinic acetylcholine receptor. J Cell Mol Med. 2020 Dec;24(24):14184-14194. doi: 10.1111/jcmm.16029. Epub 2020 Oct 27. [PubMed:33111502 ]
- D TK, Jain N, Kumar S U, Jena PP, Ramamoorthy S, Priya Doss C G, Zayed H: Molecular dynamics simulations to decipher the structural and functional consequences of pathogenic missense mutations in the galactosylceramidase (GALC) protein causing Krabbe's disease. J Biomol Struct Dyn. 2021 Mar;39(5):1795-1810. doi: 10.1080/07391102.2020.1742790. Epub 2020 Mar 31. [PubMed:32186243 ]
- Kesting, J. R., et al. (2009). Kesting, J. R., et al, J. Nat. Prod. 72, 312 (2009). J. Nat. Prod..
|
|---|